The differential therapeutic outcome in schizophrenia of compounds acting at D2-receptors.
Ackenheil
M
M
Department of Neurochemistry, Psychiatric Hospital, University of Munich.
D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use; D018492:Dopamine Antagonists; D006801:Humans; D011954:Receptors, Dopamine / Q000187:drug effects*; D017448:Receptors, Dopamine D2; D012559:Schizophrenia / Q000188:drug therapy*
D001549:Benzamides; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2